Search This Blog

Monday, August 12, 2019

Gritstone Oncology EPS misses by $0.01, misses on revenue

Gritstone Oncology (NASDAQ:GRTS): Q2 GAAP EPS of -$0.63 misses by $0.01.
Revenue of $1.15M misses by $0.17M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)